Total submissions: 18
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000078058 | SCV000109896 | benign | not specified | 2013-03-01 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000078058 | SCV000301738 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000144575 | SCV000394420 | benign | Bloom syndrome | 2018-03-06 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Ambry Genetics | RCV000568944 | SCV000672859 | benign | Hereditary cancer-predisposing syndrome | 2016-08-12 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000586013 | SCV000694478 | benign | not provided | 2016-08-31 | criteria provided, single submitter | clinical testing | Variant summary: The BLM c.2603C>T (p.Pro868Leu) variant involves the alteration of a conserved nucleotide. 2/2 in silico tools predict a damaging outcome for this variant. This variant was found in 6732/120402 control chromosomes (223 homozygotes) at a frequency of 0.0559127, which is approximately 16 times the estimated maximal expected allele frequency of a pathogenic BLM variant (0.0035355), suggesting this variant is likely a benign polymorphism. Functional studies suggest partial loss of funciton (Mirzaei_2012, Shastri_2015), however the prevalence in the general population as well as numerous homozygous occurrences indicate this variant is insufficient for full-scale Bloom syndrome. In addition, multiple clinical diagnostic laboratories/reputable databases classified this variant as benign/likely benign. Taken together, this variant is classified as benign. |
Invitae | RCV000144575 | SCV001000589 | benign | Bloom syndrome | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000144575 | SCV001623022 | benign | Bloom syndrome | 2021-05-18 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000586013 | SCV001865926 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 29484706, 24728327, 24816114, 26788541, 27153395, 19945966, 23129629) |
ARUP Laboratories, |
RCV000144575 | SCV002049304 | benign | Bloom syndrome | 2021-02-04 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV000144575 | SCV004016380 | benign | Bloom syndrome | 2023-07-07 | criteria provided, single submitter | clinical testing | |
ITMI | RCV000078058 | SCV000084373 | not provided | not specified | 2013-09-19 | no assertion provided | reference population | |
Genetic Services Laboratory, |
RCV000078058 | SCV000150444 | likely benign | not specified | no assertion criteria provided | clinical testing | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. | |
Pathway Genomics | RCV000144575 | SCV000189874 | likely benign | Bloom syndrome | 2014-07-24 | no assertion criteria provided | clinical testing | |
Diagnostic Laboratory, |
RCV000144575 | SCV000733481 | benign | Bloom syndrome | no assertion criteria provided | clinical testing | ||
Natera, |
RCV000144575 | SCV001190658 | benign | Bloom syndrome | 2019-05-20 | no assertion criteria provided | clinical testing | |
Natera, |
RCV001824121 | SCV001454859 | benign | Hereditary disease | 2020-09-16 | no assertion criteria provided | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000586013 | SCV001932382 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000078058 | SCV001957523 | benign | not specified | no assertion criteria provided | clinical testing |